Markus Schwaiger
Overview
Explore the profile of Markus Schwaiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
536
Citations
17816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian M, Chai Z, Chen L, Chiti A, Civelek C, Endo K, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39825922
No abstract available.
2.
Wurzer A, De Rose F, Fischer S, Schwaiger M, Weber W, Nekolla S, et al.
EJNMMI Radiopharm Chem
. 2024 Feb;
9(1):18.
PMID: 38407630
Background: Radiohybrid PSMA-targeted ligands (rhPSMA) have been introduced as a novel platform for theranostic applications. Among a variety of rhPSMA-ligands developed for radioligand therapy, two stereoisomers [Lu]Lu-rhPSMA-10.1 and -10.2 have...
3.
Koppara T, Dregely I, Nekolla S, Nahrig J, Langwieser N, Bradaric C, et al.
Front Cardiovasc Med
. 2024 Feb;
11:1352696.
PMID: 38404725
Background: Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is a novel hybrid imaging method integrating the advances of morphological tissue characterization of MRI with the pathophysiological insights...
4.
Morath V, Brandt C, Deuschle F, Mendler C, Blechert B, Summer D, et al.
Mol Pharm
. 2023 Apr;
20(5):2490-2501.
PMID: 37068305
Anticalin proteins directed against the prostate-specific membrane antigen (PSMA), optionally having tailored plasma half-life using PASylation technology, show promise as radioligands for PET-imaging of xenograft tumors in mice. To investigate...
5.
Lu J, Wang M, Wu P, Yakushev I, Zhang H, Ziegler S, et al.
Phenomics
. 2023 Mar;
3(1):50-63.
PMID: 36939769
Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-022-00079-6.
6.
Afshar-Oromieh A, Eiber M, Fendler W, Schmidt M, Rahbar K, Ahmadzadehfar H, et al.
Nuklearmedizin
. 2023 Feb;
62(1):5-19.
PMID: 36746147
PSMA-PET/CT for imaging prostate cancer (PC) has spread worldwide since its clinical introduction in 2011. The majority of experiences have been collected for PSMA-PET-imaging of recurrent PC. Data for primary...
7.
Barton A, Tzolos E, Bing R, Singh T, Weber W, Schwaiger M, et al.
Eur Heart J Cardiovasc Imaging
. 2022 Dec;
24(3):261-275.
PMID: 36575058
Myocardial fibrosis is the heart's common healing response to injury. While initially seeking to optimize the strength of diseased tissue, fibrosis can become maladaptive, producing stiff poorly functioning and pro-arrhythmic...
8.
Lorenzen S, Quante M, Rauscher I, Slotta-Huspenina J, Weichert W, Feith M, et al.
Eur J Cancer
. 2022 Sep;
175:99-106.
PMID: 36099671
Background: Positron emission tomography (PET) may differentiate responding and non-responding tumours early in the treatment of locally advanced gastroesophageal junction adenocarcinomas. Early PET non-responders (P-NR) after induction CTX might benefit...
9.
Zhao Y, Wu P, Wu J, Brendel M, Lu J, Ge J, et al.
Eur J Nucl Med Mol Imaging
. 2022 May;
49(8):2798-2811.
PMID: 35588012
Purpose: This work attempts to decode the discriminative information in dopamine transporter (DAT) imaging using deep learning for the differential diagnosis of parkinsonism. Methods: This study involved 1017 subjects who...
10.
Varasteh Z, Braeuer M, Mohanta S, Steinsiek A, Habenicht A, Omidvari N, et al.
Front Cardiovasc Med
. 2022 May;
9:889963.
PMID: 35548425
Introduction And Objectives: Wound healing after myocardial infarction (MI) is a dynamic and complex multiple phase process, and a coordinated cellular response is required for proper scar formation. The current...